Project Results for Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2

You may use, distribute or copy the information in these data tables, with attribution to Biomonitoring California.
For more information, visit our researchers page or contact us.
Results on page last updated:

Chemical Group: Organochlorine Pesticides

  • Measured in: Serum
  • Study Group Subset: Subsample 1

Unweighted Results

Chemical measured Indicates Exposure to Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
beta-Hexachlorocyclohexane (beta-HCH) b-HCH ng/g lipid 242 * * * <LOD 3.05 4.39 7.84 64.5% 0.0160 and 0.0180 ng/mL**
DDE (para,para) para,para-DDT and/or para,para-DDE ng/g lipid 242 47.6 42.6 53.3 29.0 41.4 65.8 221 100% 0.0181 and 0.0359 ng/mL**
DDT (ortho,para) ortho,para-DDT ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 1.2% 0.0160 and 0.0180 ng/mL**
DDT (para,para) para,para-DDT ng/g lipid 242 * * * <LOD <LOD <LOD 2.98 9.1% 0.0160 and 0.0180 ng/mL**
Hexachlorobenzene (HCB) HCB ng/g lipid 242 11.4 10.8 11.9 8.98 11.2 13.5 21.7 93.4% 0.0399 and 0.0875 ng/mL**
Oxychlordane Chlordane ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 4.5% 0.0160 and 0.0180 ng/mL**
trans-Nonachlor Chlordane ng/g lipid 242 * * * <LOD <LOD <LOD 2.18 24.4% 0.0160 and 0.0180 ng/mL**

Chemical Group: Polybrominated Diphenyl Ethers (PBDEs)

  • Measured in: Serum
  • Study Group Subset: Subsample 1

Unweighted Results

Chemical measured Indicates Exposure to Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
BDE 017 BDE 17 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 2.0% 0.0160 ng/mL
BDE 028 BDE 28 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 2.9% 0.0160 ng/mL
BDE 047 BDE 47 ng/g lipid 245 * * * <LOD <LOD 13.6 33.4 46.5% 0.0640 ng/mL
BDE 066 BDE 66 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.2% 0.0160 ng/mL
BDE 085 BDE 85 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.6% 0.0160 ng/mL
BDE 099 BDE 99 ng/g lipid 245 * * * <LOD <LOD 4.97 11.5 26.9% 0.0350 ng/mL
BDE 100 BDE 100 ng/g lipid 245 * * * <LOD <LOD 3.59 8.99 46.5% 0.0160 ng/mL
BDE 153 BDE 153 ng/g lipid 245 * * * <LOD 6.68 11.3 25.2 58.4% 0.0320 ng/mL
BDE 154 BDE 154 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 2.0% 0.0320 ng/mL
BDE 183 BDE 183 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.2% 0.0320 ng/mL
BDE 196 BDE 196 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.6% 0.0320 ng/mL
BDE 197 BDE 197 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 3.3% 0.0320 ng/mL
BDE 201 BDE 201 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.2% 0.0320 ng/mL
BDE 202 BDE 202 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.2% 0.0320 ng/mL
BDE 203 BDE 203 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.6% 0.0320 ng/mL
BDE 206 BDE 206 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.2% 0.0400 ng/mL
BDE 207 BDE 207 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 2.9% 0.0400 ng/mL
BDE 208 BDE 208 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 1.6% 0.0400 ng/mL
BDE 209 BDE 209 ng/g lipid 245 * * * <LOD <LOD <LOD <LOD 2.0% 0.300 ng/mL

Chemical Group: Polychlorinated Biphenyls (PCBs)

  • Measured in: Serum
  • Study Group Subset: Subsample 1

Unweighted Results

Chemical measured Indicates Exposure to Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
PCB 066 PCB 66 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 1.2% 0.0160 and 0.0180 ng/mL**
PCB 074 PCB 74 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 1.7% 0.0160 and 0.0180 ng/mL**
PCB 099 PCB 99 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 3.3% 0.0160 and 0.0180 ng/mL**
PCB 101 PCB 101 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 0.8% 0.0160 and 0.0180 ng/mL**
PCB 105 PCB 105 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 0.8% 0.0160 and 0.0180 ng/mL**
PCB 118 PCB 118 ng/g lipid 242 * * * <LOD <LOD <LOD 3.03 16.9% 0.0160 and 0.0180 ng/mL**
PCB 138 PCB 138 ng/g lipid 242 * * * <LOD 2.50 3.45 5.80 56.2% 0.0160 and 0.0180 ng/mL**
PCB 153 PCB 153 ng/g lipid 242 3.16 2.93 3.41 <LOD 2.89 4.41 8.25 65.3% 0.0160 and 0.0180 ng/mL**
PCB 156 PCB 156 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 2.1% 0.0160 and 0.0180 ng/mL**
PCB 170 PCB 170 ng/g lipid 242 * * * <LOD <LOD <LOD 3.64 18.2% 0.0160 and 0.0180 ng/mL**
PCB 180 PCB 180 ng/g lipid 242 * * * <LOD 2.66 4.04 8.43 59.9% 0.0160 and 0.0180 ng/mL**
PCB 183 PCB 183 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 2.1% 0.0160 and 0.0180 ng/mL**
PCB 187 PCB 187 ng/g lipid 242 * * * <LOD <LOD <LOD 3.29 11.6% 0.0160 and 0.0180 ng/mL**
PCB 194 PCB 194 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 5.0% 0.0160 and 0.0180 ng/mL**
PCB 203 PCB 203 ng/g lipid 242 * * * <LOD <LOD 2.69 4.35 26.9% 0.0173 and 0.0188 ng/mL**

Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)

  • Measured in: Serum
  • Study Group Subset: Subsample 2

Unweighted Results

Chemical measured Indicates Exposure to Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
4:2 FTS 4:2 FTS ng/mL 292 * * * <LOD <LOD <LOD 0.0463 6.2% 0.0372 ng/mL
5:3 FTCA 5:3 FTCA ng/mL 292 * * * <LOD <LOD <LOD <LOD 1.7% 0.0500 ng/mL
6:2 diPAP 6:2 diPAP ng/mL 277 * * * <LOD <LOD <LOD <LOD 2.5% 0.0645 ng/mL
6:2 FTCA 6:2 FTCA ng/mL 292 * * * <LOD <LOD <LOD <LOD 0% 0.250 ng/mL
6:2 FTS 6:2 FTS ng/mL 240 * * * <LOD <LOD <LOD 0.781 20.8% 0.188 ng/mL
6:2 FTUCA 6:2 FTUCA ng/mL 292 * * * <LOD <LOD <LOD <LOD 0% 0.0243 ng/mL
6:6 PFPiA 6:6 PFPiA ng/mL 292 * * * <LOD <LOD <LOD <LOD 0% 0.0429 ng/mL
7:3 FTCA 7:3 FTCA ng/mL 291 * * * <LOD <LOD <LOD <LOD 4.8% 0.0622 ng/mL
8:2 diPAP 8:2 diPAP ng/mL 291 * * * <LOD <LOD <LOD <LOD 0% 0.250 ng/ml
8:2 FTCA 8:2 FTCA ng/mL 292 * * * <LOD <LOD <LOD <LOD 0% 0.250 ng/mL
8:2 FTS 8:2 FTS ng/mL 290 * * * <LOD <LOD <LOD <LOD 1.4% 0.0500 ng/mL
8:2 FTUCA 8:2 FTUCA ng/mL 292 * * * <LOD <LOD <LOD <LOD 0.3% 0.0280 ng/mL
Et-PFOSA-AcOH Et-PFOSA-AcOH ng/mL 292 * * * <LOD <LOD 0.0179 0.0398 35.6% 0.0131 ng/mL
Me-PFOSA-AcOH Me-PFOSA-AcOH ng/mL 292 * * * <LOD <LOD 0.107 0.287 45.5% 0.0638 ng/mL
PFBA PFBA ng/mL 292 0.0577 0.0550 0.0606 <LOD 0.0594 0.0770 0.121 65.8% 0.0500 ng/mL
PFBS PFBS ng/mL 292 * * * <LOD <LOD 0.0119 0.0283 25.0% 0.0140 ng/mL
PFDA PFDA ng/mL 292 0.213 0.196 0.231 0.135 0.189 0.320 0.752 99.0% 0.0542 ng/mL
PFDoA PFDoA ng/mL 292 * * * <LOD <LOD <LOD 0.0854 16.4% 0.0500 ng/mL
PFDS PFDS ng/mL 292 * * * <LOD <LOD <LOD 0.0308 5.8% 0.0274 ng/mL
PFHpA PFHpA ng/mL 292 * * * <LOD <LOD <LOD 0.103 24.0% 0.0500 ng/ml
PFHxA PFHxA ng/mL 292 * * * <LOD <LOD <LOD 0.0925 5.5% 0.0818 ng/mL
PFHxPA PFHxPA ng/mL 292 * * * <LOD <LOD <LOD <LOD 0% 0.0500 ng/mL
PFHxS PFHxS ng/mL 292 0.743 0.690 0.800 0.496 0.720 1.00 2.66 100% 0.0195 ng/ml
PFNA PFNA ng/mL 292 0.542 0.509 0.578 0.372 0.527 0.774 1.39 100% 0.0487 ng/mL
PFOA PFOA ng/mL 292 1.01 0.942 1.09 0.631 1.02 1.55 2.88 100% 0.0539 ng/mL
PFOS PFOS ng/mL 292 3.10 2.88 3.33 2.05 3.09 4.41 9.07 100% 0.316 ng/mL
PFOSA PFOSA ng/mL 292 * * * <LOD <LOD <LOD <LOD 2.4% 0.0173 ng/mL
PFPeA PFPeA ng/mL 292 * * * <LOD <LOD <LOD 0.0255 6.5% 0.0235 ng/mL
PFUnDA PFUnDA ng/mL 292 0.129 0.115 0.145 0.0646 0.118 0.275 0.726 81.2% 0.0481 ng/mL